loadpatents
name:-0.042532920837402
name:-0.018393993377686
name:-0.018723011016846
KOLTUN; Elena S. Patent Filings

KOLTUN; Elena S.

Patent Applications and Registrations

Patent applications and USPTO patent grants for KOLTUN; Elena S..The latest application filed is for "bicyclic heteroaryl compounds and uses thereof".

Company Profile
17.18.35
  • KOLTUN; Elena S. - Redwood City CA
  • KOLTUN; Elena S. - Foster City CA
  • Koltun; Elena S. - Boston MA
  • Koltun; Elena S. - San Francisco CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Bicyclic Heteroaryl Compounds And Uses Thereof
App 20220135584 - BUCKL; Andreas ;   et al.
2022-05-05
Ras Inhibitors
App 20220105185 - AAY; Naing ;   et al.
2022-04-07
Bicyclic Compounds Useful As Gpr120 Modulators
App 20210347768 - Raimundo; Brian ;   et al.
2021-11-11
Bicyclic heteroaryl compounds and uses thereof
Grant 11,168,102 - Gill , et al. November 9, 2
2021-11-09
Bicyclic Heteroaryl Compounds And Uses Thereof
App 20210139517 - Gill; Adrian L. ;   et al.
2021-05-13
Ras Inhibitors
App 20210130369 - KOLTUN; Elena S. ;   et al.
2021-05-06
Ras Inhibitors
App 20210130303 - KOLTUN; Elena S. ;   et al.
2021-05-06
Ras Inhibitors
App 20210130326 - AGGEN; James ;   et al.
2021-05-06
Monocyclic Compounds Useful As Gpr120 Modulators
App 20210101896 - Raimundo; Brian ;   et al.
2021-04-08
2,5-disubstituted 3-methyl Pyrazines And 2,5,6-trisubstituted 3-methyl Pyrazines As Allosteric Shp2 Inhibitors
App 20210101870 - KOLTUN; Elena S. ;   et al.
2021-04-08
Derivatives of amphotericin B
Grant 10,882,883 - Burke , et al. January 5, 2
2021-01-05
Polycyclic Compounds As Allosteric Shp2 Inhibitors
App 20200407372 - KOLTUN; Elena S. ;   et al.
2020-12-31
Bicyclic compounds useful as GPR120 modulators
Grant 10,865,201 - Raimundo , et al. December 15, 2
2020-12-15
Pyridine, Pyrazine, And Triazine Compounds As Allosteric Shp2 Inhibitors
App 20200339552 - LI; Jie Jack ;   et al.
2020-10-29
Monocyclic compounds useful as GPR120 modulators
Grant 10,800,773 - Raimundo , et al. October 13, 2
2020-10-13
MEK Inhibitors and Methods of Their Use
App 20200283383 - Aay; Naing ;   et al.
2020-09-10
Derivatives Of Amphotericin B
App 20200262858 - Burke; Martin D. ;   et al.
2020-08-20
Compounds That Participate In Cooperative Binding And Uses Thereof
App 20200197391 - JIN; Meizhong ;   et al.
2020-06-25
Derivatives of amphotericin B
Grant 10,597,420 - Burke , et al.
2020-03-24
2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors
Grant 10,590,090 - Koltun , et al.
2020-03-17
Mek Inhibitors And Methods Of Their Use
App 20200031770 - Aay; Naing ;   et al.
2020-01-30
Bicyclic Compounds As Allosteric Shp2 Inhibitors
App 20200017511 - BLANK; Brian R. ;   et al.
2020-01-16
Pyridine Compounds As Allosteric Shp2 Inhibitors
App 20200017517 - GILL; Adrian ;   et al.
2020-01-16
Bicyclic Compounds Useful As Gpr120 Modulators
App 20190218208 - Raimundo; Brian ;   et al.
2019-07-18
2,5-disubstituted 3-methyl Pyrazines And 2,5,6-trisubstituted 3-methyl Pyrazines As Allosteric Shp2 Inhibitors
App 20190210977 - JOGALEKAR; Ashutosh ;   et al.
2019-07-11
Monocyclic Compounds Useful As Gpr120 Modulators
App 20190202821 - Raimundo; Brian ;   et al.
2019-07-04
MEK Inhibitors and Methods of Their Use
App 20190144382 - Aay; Naing ;   et al.
2019-05-16
Derivatives Of Amphotericin B
App 20180273572 - Burke; Martin D. ;   et al.
2018-09-27
ROR.gamma. modulators
Grant 10,035,790 - Xu , et al. July 31, 2
2018-07-31
Derivatives of amphotericin B
Grant 9,957,290 - Burke , et al. May 1, 2
2018-05-01
MEK Inhibitors And Methods Of Their Use
App 20170166523 - Aay; Naing ;   et al.
2017-06-15
RORGamma Modulators
App 20150266856 - Xu; Wei ;   et al.
2015-09-24
MEK Inhibitors And Methods Of Their Use
App 20150141399 - Aay; Naing ;   et al.
2015-05-21
Azetidines as MEK Inhibitors for the Treatment of Proliferative Diseases
App 20140275527 - Aay; Naing ;   et al.
2014-09-18
4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as JAK-2 modulators and methods of use
Grant 8,440,663 - Mann , et al. May 14, 2
2013-05-14
Azetidines as MEK inhibitors for the treatment of proliferative diseases
Grant 8,362,002 - Aay , et al. January 29, 2
2013-01-29
Pyrimidinones as casein kinase II (CK2) modulators
Grant 8,324,231 - Koltun , et al. December 4, 2
2012-12-04
6-phenylpyrimidinones as PIM modulators
Grant 8,242,129 - Tsuhako , et al. August 14, 2
2012-08-14
Pyrimidinones as Casein Kinase II (CK2) modulators
Grant 8,101,625 - Rice , et al. January 24, 2
2012-01-24
Pyridopyrimidinone inhibitors of PIM-1 and/or PIM-3
Grant 8,053,454 - Kearney , et al. November 8, 2
2011-11-08
Azetidines as MEK Inhibitors for the Treatment of Proliferative Diseases
App 20110263558 - Aay; Naing ;   et al.
2011-10-27
Azetidines as MEK inhibitors for the treatment of proliferative diseases
Grant 7,915,250 - Aay , et al. March 29, 2
2011-03-29
Azetidines as MEK Inhibitors for the Treatment of Proliferative Diseases
App 20100249096 - Aay; Naing ;   et al.
2010-09-30
Azetidines as MEK inhibitors for the treatment of proliferative diseases
Grant 7,803,839 - Aay , et al. September 28, 2
2010-09-28
Pyrimidinones as Casein Kinase II (CK2) Modulators
App 20100144770 - Koltun; Elena S. ;   et al.
2010-06-10
6-Phenylpyrimidinones as PIM Modulators
App 20100135954 - Tsuhako; Amy L. ;   et al.
2010-06-03
4-Aryl-2-Amino-Pyrimidnes or 4-Aryl-2-Aminoalkyl-Pyrimidines as Jak-2 Modulators and Methods of Use
App 20090298830 - Mann; Grace ;   et al.
2009-12-03
Benzofuropyrimidinones
App 20090247559 - Brown; S. David ;   et al.
2009-10-01
Pyrimidinones as Casein Kinase II (CK2) Modulators
App 20090215803 - Rice; Kenneth D. ;   et al.
2009-08-27
Azetidines as MEK Inhibitors for the Treatment of Proliferative Diseases
App 20090156576 - Aay; Naing ;   et al.
2009-06-18
Pyridopyrimidinone Inhibitors of PIM-1 and/or PIM-3
App 20090042918 - Kearney; Patrick ;   et al.
2009-02-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed